Press release
Deadline coming up in Lawsuit for certain Investors in shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)
A Deadline is coming up on September 29, 2023 in the lawsuit for certain investors in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX).
Investors who purchased shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) have certain options and there are strict and short deadlines running. Deadline: September 29, 2023. NASDAQ: ALDX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of Massachusetts the plaintiff alleges on behalf of purchasers of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) common shares between March 17, 2022 and June 20, 2023, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that between March 17, 2022 and June 20, 2023, the Defendants made false and/or misleading statements and/or failed to disclose that the ADX-2191 NDA did not include adequate and well-controlled investigations and thus failed to show substantial evidence of ADX-2191's effectiveness, that as a result, the FDA was unlikely to approve the ADX-2191 NDA in its current form, that accordingly, the Company had overstated ADX-2191's clinical and/or commercial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline coming up in Lawsuit for certain Investors in shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) here
News-ID: 3212809 • Views: 359
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors who lost money with shares of Do …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Doximity, Inc.
Investors who purchased shares of Doximity, Inc. (NYSE: DOCS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Doximity, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Francsico, CA based…
Investigation announced for Long-Term Investors in shares of Funko, Inc. (NASDAQ …
An investigation was announced for investors in shares of Funko, Inc. (NASDAQ: FNKO) concerning potential breaches of fiduciary duties by certain directors and officers of Funko, Inc..
Investors who are current long term investors in Funko, Inc. (NASDAQ: FNKO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: FNKO…
Investigation announced for Investors in shares of Reata Pharmaceuticals, Inc. ( …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Reata Pharmaceuticals, Inc.
Investors who purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Reata Pharmaceuticals, Inc. officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Plano,…
Investigation announced for Investors who lost money with shares of Semtech Corp …
An investigation was announced for investors of Semtech Corporation (NASDAQ: SMTC) shares over potential securities laws violations by Semtech Corporation.
Investors who purchased shares of Semtech Corporation (NASDAQ: SMTC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Semtech Corporation (NASDAQ: SMTC) concerning whether a series…
More Releases for Aldeyra
Sicca Syndrome Market Outlook, trend analysis, Competitive Landscape and Growth …
The Sicca Syndrome Market Report 2021 report provides the latest industry data and future industry trends. The report lists leading competitors and manufacturers in the Sicca Syndrome industry and provides strategic industry insights and analysis of factors influencing the competitiveness of the market. The geographical scope of the Sicca Syndrome market is studied. The forecast market information, SWOT analysis, market scenario, and feasibility study are the vital aspects analyzed in this report.
Our…
Allergic Conjunctivitis Drug Market future scenario and trend analysis with key …
The commonness of conjunctivitis or pink eye is expanding all around the world, powering market development. Conjunctivitis drugs are utilized for the treatment of conjunctivitis. There are different sorts of conjunctivitis including bacterial, unfavorably susceptible, viral, and synthetic. Conjunctivitis influences a great many individuals and forces financial and social weights. In the US, it is assessed that intense conjunctivitis influences around 6 million individuals yearly. The central point impacting the…
2020 Allergic Conjunctivitis Market Report- Trends, Top Manufactures, Size, Mark …
The research reports on Allergic Conjunctivitis Market report gives detailed overview of factors that affect global business scope. Allergic Conjunctivitis Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. Allergic Conjunctivitis Market report contains emerging players analyze data including competitive situations, sales, revenue and market share of top manufacturers.
Get FREE…
Panuveitis Treatment Market To Grow Rapidly By 2026|Aldeyra Therapeutics, Inc, B …
Global panuveitis treatment market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Emergence of drugs used to treat risk associated with panuveitis and high demand of disease specific novel therapies are the key factors that fueling the market growth
The panuveitis treatment market research report includes a thorough analysis of the market drivers, restraints, threats, and opportunities while it also addresses the lucrative investment options…
Incredible Growth by Medical Informatics Market by 2025| Leading Players Acadia …
Global Medical Informatics Market is predictable to grow at a CAGR of +13% over the forecast period 2019-2025. The Market has a high demand in the North American market on account of increased adoption of technological advanced systems and IoT technologies.
The Medical Information Market consists of issues relating to the collection, storage and analysis of medical information in digital form. Medical Informatics improves the quality and efficiency of medical and…
Allergic Conjunctivitis Drug Market Share, Growth, Trends and Forecast to 2025- …
"The analysis presents a comprehensive evaluation of this global Allergic Conjunctivitis Drug market allowing technologies, key trends and market drivers, challenges, and standardization, regulatory arena, installation units, and operator case studies, Allergic Conjunctivitis Drug opportunities, future road map, value series, eco-system player profiles, and strategies. The Allergic Conjunctivitis Drug report introduces predictions for important decisions from 2019 to 2025.
The Allergic Conjunctivitis Drug Market report provides key driving factors which can…
